Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1-Reference-Cited by-同舟云学术

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1

Published:2023-10-26 Issue:2 Volume:12 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Hu Yanping¹,Zou Jing¹,Kurhade Chaitanya¹,Deng Xiangxue²,Chang Hope C.³,Kim Debora K.³,Shi Pei-Yong¹,Ren Ping³,Xie Xuping¹⁴

Affiliation:

1. Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA

2. Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA

3. Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA

4. Sealy Institute for Drug Discovery, University of Texas Medical Branch, Galveston, TX, USA

Funder

National Institutes of Health

Sealy & Smith Foundation, the Kleberg Foundation, the John S. Dunn Foundation, the Amon G. Carter Foundation, the Summerfield Robert Foundation, and Edith and Robert Zinn

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2023.2271089

Reference31 articles.

1. A pneumonia outbreak associated with a new coronavirus of probable bat origin

2. Nextstrain: real-time tracking of pathogen evolution

3. Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2

4. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

5. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants;Cell;2024-02

2. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency;Cell;2024-02

3. Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster;Vaccines;2024-01-30

4. Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023;Eurosurveillance;2024-01-11

5. Anticipating the future of the COVID-19 pandemic: insights into the emergence of SARS-CoV-2 variant JN.1 and its projected impact on older adults;GeroScience;2024-01-10